MXPA01010521A - Antibacteriales de cetolidos. - Google Patents
Antibacteriales de cetolidos.Info
- Publication number
- MXPA01010521A MXPA01010521A MXPA01010521A MXPA01010521A MXPA01010521A MX PA01010521 A MXPA01010521 A MX PA01010521A MX PA01010521 A MXPA01010521 A MX PA01010521A MX PA01010521 A MXPA01010521 A MX PA01010521A MX PA01010521 A MXPA01010521 A MX PA01010521A
- Authority
- MX
- Mexico
- Prior art keywords
- ketolide
- antibacterials
- ketolide antibacterials
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 239000003835 ketolide antibiotic agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12972999P | 1999-04-16 | 1999-04-16 | |
| US13138399P | 1999-04-28 | 1999-04-28 | |
| US14017599P | 1999-06-18 | 1999-06-18 | |
| US17215999P | 1999-12-17 | 1999-12-17 | |
| US17215499P | 1999-12-17 | 1999-12-17 | |
| PCT/US2000/010276 WO2000062783A2 (en) | 1999-04-16 | 2000-04-13 | Ketolide antibacterials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01010521A true MXPA01010521A (es) | 2003-08-19 |
Family
ID=27537847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01010521A MXPA01010521A (es) | 1999-04-16 | 2000-04-13 | Antibacteriales de cetolidos. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6399582B1 (es) |
| EP (1) | EP1171447A2 (es) |
| JP (1) | JP2002542197A (es) |
| CN (1) | CN1373767A (es) |
| AU (1) | AU4354900A (es) |
| CA (1) | CA2370743A1 (es) |
| IL (1) | IL145976A0 (es) |
| MX (1) | MXPA01010521A (es) |
| NZ (1) | NZ514917A (es) |
| WO (1) | WO2000062783A2 (es) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP1060A (en) * | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
| FR2781484B1 (fr) * | 1998-07-21 | 2001-08-10 | Hoechst Marion Roussel Inc | Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments |
| ATE256694T1 (de) | 1999-01-27 | 2004-01-15 | Pfizer Prod Inc | Ketolid-antibiotika |
| EP1171446B1 (en) | 1999-04-16 | 2006-09-20 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
| US6451768B1 (en) | 1999-04-16 | 2002-09-17 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
| US6590083B1 (en) * | 1999-04-16 | 2003-07-08 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
| IL145739A0 (en) | 1999-05-24 | 2002-07-25 | Pfizer Prod Inc | 13-methyl-erythromycin derivatives |
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| WO2001060833A2 (en) | 2000-02-18 | 2001-08-23 | Kosan Biosciences, Inc. | Motilide compounds |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| EP1337540A2 (en) * | 2000-12-01 | 2003-08-27 | Kosan Biosciences, Inc. | Motilide compounds |
| US6472372B1 (en) | 2000-12-06 | 2002-10-29 | Ortho-Mcneil Pharmaceuticals, Inc. | 6-O-Carbamoyl ketolide antibacterials |
| CA2460947A1 (en) | 2001-09-17 | 2003-03-27 | Ortho-Mcneil Pharmaceutical, Inc. | 6-o-carbamate-11,12-lacto-ketolide antimicrobials |
| CN1585775A (zh) | 2001-12-05 | 2005-02-23 | 奥索-麦克尼尔药品公司 | 可用作抗菌药的红霉素的6－o－酰基酮内酯衍生物 |
| US8063021B2 (en) * | 2002-01-17 | 2011-11-22 | Kosan Biosciences Incorporated | Ketolide anti-infective compounds |
| US20050267054A1 (en) * | 2002-04-30 | 2005-12-01 | Clark Richard F | Antibacterial compounds with improved pharmacokinetic profiles |
| US20040033970A1 (en) * | 2002-04-30 | 2004-02-19 | Clark Richard F. | Antibacterial compounds with improved pharmacokinetic profiles |
| US6753318B1 (en) | 2002-07-25 | 2004-06-22 | Enanta Pharmaceuticals, Inc. | 6,11-4-carbon bridged erythromycin derivatives |
| US6878691B2 (en) * | 2002-05-13 | 2005-04-12 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
| WO2005070918A1 (en) * | 2002-05-13 | 2005-08-04 | Enanta Pharmaceuticals, Inc. | Process for the preparation of t-11 bicyclic erythromycin derivatives |
| US6764998B1 (en) | 2003-06-18 | 2004-07-20 | Enanta Pharmaceuticals, Inc. | 6,11-4C-bicyclic 9a-azalide derivatives |
| JP2005536465A (ja) * | 2002-05-13 | 2005-12-02 | エナンタ ファーマシューティカルズ インコーポレイテッド | ６，１１二環式エリスロマイシン誘導体 |
| US7273853B2 (en) * | 2002-05-13 | 2007-09-25 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
| US7910558B2 (en) * | 2002-05-13 | 2011-03-22 | Enanta Pharmaceuticals, Inc. | Bridged macrocyclic compounds and processes for the preparation thereof |
| US6841664B2 (en) | 2002-07-25 | 2005-01-11 | Enanra Pharmaceuticals, Inc. | 6,11-4-carbon bridged ketolides |
| US7135573B2 (en) * | 2002-05-13 | 2006-11-14 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine |
| US7064110B2 (en) * | 2002-05-13 | 2006-06-20 | Enanta Pharmaceuticals, Inc. | 6-11 bicycle ketolide derivatives |
| US6825172B2 (en) | 2002-05-31 | 2004-11-30 | Janssen Pharmaceutica, Nv | 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents |
| US6727229B2 (en) * | 2002-08-19 | 2004-04-27 | Enanta Pharmaceuticals, Inc. | 11,12-substituted lactone ketolide derivatives having antibacterial activity |
| CA2801100A1 (en) | 2003-03-10 | 2004-09-23 | Optimer Pharmaceuticals, Inc. | Macrolides and processes for their preparation |
| US6645941B1 (en) | 2003-03-26 | 2003-11-11 | Enanta Pharmaceuticals, Inc. | 6,11-3C-bicyclic 9a-azalide derivatives |
| US20040254126A1 (en) * | 2003-06-05 | 2004-12-16 | Yao-Ling Qiu | 11-12 Bicyclic erythromycin derivatives |
| US6790835B1 (en) | 2003-06-05 | 2004-09-14 | Enanta Pharmaceuticals, Inc. | Bicyclic macrolide derivatives |
| US6716820B1 (en) | 2003-06-05 | 2004-04-06 | Enanta Pharmaceuticals, Inc. | 6-O-substituted bicyclic macrolides |
| US6774115B1 (en) | 2003-06-05 | 2004-08-10 | Enanta Pharmaceuticals, Inc. | 6-O-substituted bicyclic ketolides |
| US6765016B1 (en) | 2003-06-05 | 2004-07-20 | Enanta Pharmaceuticals, Inc. | Bicyclic ketolide derivatives |
| US7407941B2 (en) * | 2003-08-26 | 2008-08-05 | Pfizer, Inc. | N-desmethyl-N-substituted-11-deoxyerythromycin compounds |
| US20050113319A1 (en) * | 2003-08-26 | 2005-05-26 | Christopher Carreras | 11-Deoxy-6,9-ether erythromycin compounds |
| US7276487B2 (en) * | 2003-09-23 | 2007-10-02 | Enanta Pharmaceuticals, Inc. | 9a, 11-3C-bicyclic 9a-azalide derivatives |
| US7414030B2 (en) | 2004-01-07 | 2008-08-19 | Enanta Pharmaceuticals, Inc. | 6-11 Bicyclic erythromycin derivatives |
| WO2005070113A2 (en) * | 2004-01-09 | 2005-08-04 | Enanta Pharmaceuticals, Inc. | 9n-substituted 6-11 bicyclic erythromycin derivatives |
| RU2397987C2 (ru) * | 2004-07-28 | 2010-08-27 | Рэнбакси Лабораториз Лимитед | Кетолидные производные в качестве антибактериальных агентов |
| CA2572442A1 (fr) * | 2004-07-30 | 2006-03-09 | Palumed S.A. | Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien |
| FR2874922A1 (fr) * | 2004-07-30 | 2006-03-10 | Palumed Sa | Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien |
| US20090170790A1 (en) * | 2004-10-25 | 2009-07-02 | Biswajit Das | Ketolide derivatives as antibacterial agents |
| CN101120011A (zh) * | 2004-12-21 | 2008-02-06 | 辉瑞产品公司 | 大环内酯 |
| US20100035832A1 (en) * | 2005-01-12 | 2010-02-11 | Alpharma Aps | Macrolides |
| US7384922B2 (en) * | 2005-05-04 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | 6-11 bridged oxime erythromycin derivatives |
| EP1957508A2 (en) * | 2005-11-23 | 2008-08-20 | Ranbaxy Laboratories Limited | Ketolide derivatives as antibacterial agents |
| US20090130225A1 (en) * | 2005-11-23 | 2009-05-21 | Anjan Chakrabarti | Macrolides derivatives as antibacterial agents |
| US7595300B2 (en) | 2005-12-13 | 2009-09-29 | Kosan Biosciences Incorporated | 7-quinolyl ketolide antibacterial agents |
| CN100577678C (zh) * | 2006-06-19 | 2010-01-06 | 中国医学科学院药物研究所 | 大环内酯类药物双侧链红霉素a衍生物、合成方法和用途 |
| US8354383B2 (en) * | 2007-09-17 | 2013-01-15 | Enanta Pharmaceuticals, Inc. | 6,11-bridged biaryl macrolides |
| KR101223158B1 (ko) * | 2007-09-17 | 2013-01-17 | 이난타 파마슈티칼스, 인코포레이티드 | 6,11-다리걸친 바이아릴 매크로라이드 |
| US8273720B2 (en) * | 2007-09-17 | 2012-09-25 | Enanta Pharmaceuticals, Inc. | 6,11-bicyclolides: bridged biaryl macrolide derivatives |
| AU2008316830B2 (en) | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| CN102245195B (zh) | 2008-10-24 | 2016-01-13 | 森普拉制药公司 | 使用含三唑的大环内酯的生物防御 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| CN102724874B (zh) | 2009-09-10 | 2018-06-01 | 森普拉制药公司 | 治疗疟疾、结核病和mac疾病的方法 |
| CN108570083A (zh) | 2010-03-22 | 2018-09-25 | 森普拉制药公司 | 大环内脂的结晶形式及其用途 |
| CN102917708B (zh) | 2010-05-20 | 2015-11-25 | 森普拉制药公司 | 制备大环内酯和酮内酯及其中间体的方法 |
| US9815863B2 (en) | 2010-09-10 | 2017-11-14 | Cempra Pharmaceuticals, Inc. | Hydrogen bond forming fluoro ketolides for treating diseases |
| KR20140139083A (ko) | 2012-03-27 | 2014-12-04 | 셈프라 파마슈티컬스, 인크. | 마크롤라이드계 항생제를 투여하기 위한 비경구 제제 |
| CA2905975A1 (en) | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| JP6675973B2 (ja) | 2013-03-15 | 2020-04-08 | センプラ ファーマシューティカルズ，インコーポレイテッド | マクロライド抗菌薬を調製するための集束的な方法 |
| MX377459B (es) | 2013-04-04 | 2025-03-10 | Harvard College | Macrolidos y metodos para su preparacion y uso. |
| US10633407B2 (en) * | 2014-10-08 | 2020-04-28 | President And Fellows Of Harvard College | 14-membered ketolides and methods of their preparation and use |
| HK1250371A1 (zh) | 2015-03-25 | 2018-12-14 | President And Fellows Of Harvard College | 具有修饰的脱氧糖胺糖的大环内酯及其用途 |
| CN106554381A (zh) * | 2015-09-25 | 2017-04-05 | 苏州鹏旭医药科技有限公司 | 酮内酯类抗生素中间体及其制备方法和应用 |
| US20240076293A1 (en) * | 2020-12-28 | 2024-03-07 | Georgia Tech Research Corporation | Compositions and Methods for Inhibiting Fibrosis, Inflammation and Cancer |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4935340A (en) | 1985-06-07 | 1990-06-19 | Eli Lilly And Company | Method of isolating antibiotic biosynthetic genes |
| GB8521402D0 (en) | 1985-08-28 | 1985-10-02 | Beecham Group Plc | Chemical compounds |
| US4874748A (en) | 1986-03-24 | 1989-10-17 | Abbott Laboratories | Cloning vectors for streptomyces and use thereof in macrolide antibiotic production |
| US4742049A (en) | 1986-06-04 | 1988-05-03 | Abbott Laboratories | Semisynthetic erythromycin antibiotics |
| US5110728A (en) | 1986-07-31 | 1992-05-05 | Calgene, Inc. | Acyl carrier protein - DNA sequence and synthesis |
| JP2787458B2 (ja) | 1989-01-20 | 1998-08-20 | 旭化成工業株式会社 | 抗生物質ｌ５３―１８ａおよびその製造法 |
| US5087563A (en) | 1990-03-09 | 1992-02-11 | The United States Of America, As Represented By The Secretary Of Agriculture | Acyl carrier protein-I/protein-A gene fusion, products and methods |
| US5141926A (en) | 1990-04-18 | 1992-08-25 | Abbott Laboratories | Erythromycin derivatives |
| IL114589A (en) | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of erythromycin derivatives |
| US6060234A (en) | 1991-01-17 | 2000-05-09 | Abbott Laboratories | Polyketide derivatives and recombinant methods for making same |
| US5824513A (en) | 1991-01-17 | 1998-10-20 | Abbott Laboratories | Recombinant DNA method for producing erythromycin analogs |
| US5672491A (en) | 1993-09-20 | 1997-09-30 | The Leland Stanford Junior University | Recombinant production of novel polyketides |
| US6066721A (en) | 1995-07-06 | 2000-05-23 | Stanford University | Method to produce novel polyketides |
| US5712146A (en) | 1993-09-20 | 1998-01-27 | The Leland Stanford Junior University | Recombinant combinatorial genetic library for the production of novel polyketides |
| FR2718450B1 (fr) | 1994-04-08 | 1997-01-10 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| FR2719587B1 (fr) | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| FR2732023B1 (fr) | 1995-03-22 | 1997-04-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| ATE286133T1 (de) | 1995-07-06 | 2005-01-15 | Univ Leland Stanford Junior | Zellfreie synthese von polyketiden |
| FR2739620B1 (fr) | 1995-10-09 | 1997-12-19 | Roussel Uclaf | Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs |
| FR2742757B1 (fr) | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| US6271255B1 (en) | 1996-07-05 | 2001-08-07 | Biotica Technology Limited | Erythromycins and process for their preparation |
| DK0909327T3 (da) | 1996-07-05 | 2005-09-26 | Biotica Tech Ltd | Erythromyciner og fremgangsmåder til deres fremstilling |
| UA51730C2 (uk) * | 1996-09-04 | 2002-12-16 | Ебботт Лабораторіз | 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців |
| FR2754821B1 (fr) | 1996-10-23 | 2003-04-04 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| AU732909B2 (en) | 1997-04-30 | 2001-05-03 | Board Of Trustees Of The Leland Stanford Junior University | Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
| EP1016664B1 (en) | 1997-09-02 | 2003-07-02 | Mitsubishi Pharma Corporation | Fused thiophene compounds and medicinal use thereof |
| US6124269A (en) | 1997-10-29 | 2000-09-26 | Abbott Laboratories | 2-Halo-6-O-substituted ketolide derivatives |
| AP1060A (en) | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
| AP9801420A0 (en) | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
| FR2777282B1 (fr) | 1998-04-08 | 2001-04-20 | Hoechst Marion Roussel Inc | Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments |
| GB9814006D0 (en) | 1998-06-29 | 1998-08-26 | Biotica Tech Ltd | Polyketides and their synthesis |
| SK5812001A3 (en) | 1998-11-03 | 2001-12-03 | Pfizer Prod Inc | Novel macrolide antibiotics |
| ES2273964T3 (es) | 1998-12-10 | 2007-05-16 | Pfizer Products Inc. | Antibioticos de carbamato y carbazato cetolida. |
| ATE256694T1 (de) | 1999-01-27 | 2004-01-15 | Pfizer Prod Inc | Ketolid-antibiotika |
| IL145739A0 (en) | 1999-05-24 | 2002-07-25 | Pfizer Prod Inc | 13-methyl-erythromycin derivatives |
| PT1181300E (pt) | 1999-06-07 | 2004-02-27 | Abbott Lab | Derivados 6-o-carbamato de cetolido |
-
2000
- 2000-04-13 MX MXPA01010521A patent/MXPA01010521A/es unknown
- 2000-04-13 WO PCT/US2000/010276 patent/WO2000062783A2/en not_active Ceased
- 2000-04-13 US US09/548,568 patent/US6399582B1/en not_active Expired - Lifetime
- 2000-04-13 CN CN00809087A patent/CN1373767A/zh active Pending
- 2000-04-13 AU AU43549/00A patent/AU4354900A/en not_active Abandoned
- 2000-04-13 CA CA002370743A patent/CA2370743A1/en not_active Abandoned
- 2000-04-13 NZ NZ514917A patent/NZ514917A/xx unknown
- 2000-04-13 US US09/548,584 patent/US6458771B1/en not_active Expired - Lifetime
- 2000-04-13 JP JP2000611919A patent/JP2002542197A/ja active Pending
- 2000-04-13 IL IL14597600A patent/IL145976A0/xx unknown
- 2000-04-13 EP EP00923425A patent/EP1171447A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000062783A2 (en) | 2000-10-26 |
| JP2002542197A (ja) | 2002-12-10 |
| AU4354900A (en) | 2000-11-02 |
| WO2000062783A3 (en) | 2001-02-15 |
| US6458771B1 (en) | 2002-10-01 |
| CN1373767A (zh) | 2002-10-09 |
| US6399582B1 (en) | 2002-06-04 |
| NZ514917A (en) | 2004-02-27 |
| EP1171447A2 (en) | 2002-01-16 |
| IL145976A0 (en) | 2002-07-25 |
| CA2370743A1 (en) | 2000-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA01010521A (es) | Antibacteriales de cetolidos. | |
| MXPA01013362A (es) | Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso. | |
| ZA200200477B (en) | 2-pyrazolin-5-ones. | |
| EG24361A (en) | 4-pyrimiding1-n-acy1.l.phenlalanines | |
| ZA996185B (en) | Sulfanylsilanes. | |
| ZA992629B (en) | (4-arylsulfonylamino)-tetrahydropyran-4-caboxylic acid hydroxamides. | |
| ZA9811939B (en) | Novel macrolides. | |
| ZA200005136B (en) | Dihydropyrimides. | |
| ZA200210206B (en) | Expression system. | |
| ZA200202537B (en) | Pour-on-formulations. | |
| ZA200203762B (en) | 4-pyridinyl-IN-acyl-L-phenylalanines. | |
| MXPA03003532A (es) | Antibacterianos de cetolida. | |
| ZA200203707B (en) | Pharmaceutical combinations. | |
| ZA200107346B (en) | Erythromycin derivatives. | |
| ZA992443B (en) | Hydroxy-methyl-hexanones. | |
| ZA993123B (en) | Trisresorcinyltriazines. | |
| AU2001272351A1 (en) | Wiper system | |
| ZA995325B (en) | Methylcyclotetradec-5-en-1-ones. | |
| MXPA02000261A (es) | Aminoindanos novedosos. | |
| ZA200110454B (en) | Pharmaceutical complex. | |
| GB0029720D0 (en) | I.S machine7544232001 | |
| MXPA01011285A (es) | Derivados de tio-oxindol. | |
| ZA200204581B (en) | Nitro-sulfobenzamides. | |
| ZA200109444B (en) | Ketolide antibacterials. | |
| MXPA01013157A (es) | Perfil. |